{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:42Z","timestamp":1789042902371,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"DOI":"10.1007\/s00784-024-05516-6","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T10:02:32Z","timestamp":1706868152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Global research trends in tongue cancer from 2000 to 2022: bibliometric and visualized analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"Beibei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"5516_CR1","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/hed.26177","volume":"42","author":"E Yosefof","year":"2020","unstructured":"Yosefof E, Hilly O, Stern S, Bachar G, Shpitzer T, Mizrachi A (2020) Squamous cell carcinoma of the oral tongue: distinct epidemiological profile disease. Head Neck 42:2316\u20132320. https:\/\/doi.org\/10.1002\/hed.26177","journal-title":"Head Neck"},{"key":"5516_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA: Cancer J Clin"},{"key":"5516_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00428-020-02930-5","volume":"478","author":"A Almangush","year":"2021","unstructured":"Almangush A, Bello IO, Heikkinen I, Hagstr\u00f6m J, Haglund C, Kowalski LP, Nieminen P, Coletta RD, M\u00e4kitie AA, Salo T, Leivo I (2021) Stromal categorization in early oral tongue cancer. Virchows Archiv\u202f: Int J Pathol 478:925\u2013932. https:\/\/doi.org\/10.1007\/s00428-020-02930-5","journal-title":"Virchows Archiv : Int J Pathol"},{"key":"5516_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/01945998221098011","volume":"168","author":"KO Stepan","year":"2023","unstructured":"Stepan KO, Mazul AL, Larson J, Shah P, Jackson RS, Pipkorn P, Kang SY, Puram SV (2023) Changing epidemiology of oral cavity cancer in the United States. Otolaryngolo-Head Neck Surg 168:761\u2013768. https:\/\/doi.org\/10.1177\/01945998221098011","journal-title":"Otolaryngolo-Head Neck Surg"},{"key":"5516_CR5","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1002\/ijc.22177","volume":"119","author":"L Hammarstedt","year":"2006","unstructured":"Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620\u20132623. https:\/\/doi.org\/10.1002\/ijc.22177","journal-title":"Int J Cancer"},{"key":"5516_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/00016480601110170","volume":"127","author":"L Hammarstedt","year":"2007","unstructured":"Hammarstedt L, Dahlstrand H, Lindquist D, Onel\u00f6v L, Ryott M, Luo J, Dalianis T, Ye W, Munck-Wikland E (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988\u2013992. https:\/\/doi.org\/10.1080\/00016480601110170","journal-title":"Acta Otolaryngol"},{"key":"5516_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/cncr.22963","volume":"110","author":"EM Sturgis","year":"2007","unstructured":"Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429\u20131435. https:\/\/doi.org\/10.1002\/cncr.22963","journal-title":"Cancer"},{"key":"5516_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/jco.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol\u202f: Off J Am Soc Clin Oncol 26:612\u2013619. https:\/\/doi.org\/10.1200\/jco.2007.14.1713","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"5516_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ijc.24339","volume":"125","author":"A N\u00e4sman","year":"2009","unstructured":"N\u00e4sman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Spar\u00e9n P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125:362\u2013366. https:\/\/doi.org\/10.1002\/ijc.24339","journal-title":"Int J Cancer"},{"key":"5516_CR10","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/ijc.24994","volume":"126","author":"P Attner","year":"2010","unstructured":"Attner P, Du J, N\u00e4sman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126:2879\u20132884. https:\/\/doi.org\/10.1002\/ijc.24994","journal-title":"Int J Cancer"},{"key":"5516_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/s1470-2045(10)70017-6","volume":"11","author":"S Marur","year":"2010","unstructured":"Marur S, D\u2019Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781\u2013789. https:\/\/doi.org\/10.1016\/s1470-2045(10)70017-6","journal-title":"Lancet Oncol"},{"key":"5516_CR12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3201\/eid1611.100452","volume":"16","author":"T Ramqvist","year":"2010","unstructured":"Ramqvist T, Dalianis T (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16:1671\u20131677. https:\/\/doi.org\/10.3201\/eid1611.100452","journal-title":"Emerg Infect Dis"},{"key":"5516_CR13","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/jco.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol\u202f: Off J Am Soc Clin Oncol 29:4294\u20134301. https:\/\/doi.org\/10.1200\/jco.2011.36.4596","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"5516_CR14","volume-title":"Glossectomy","author":"JLM Bigcas","year":"2023","unstructured":"Bigcas JLM, Okuyemi OT (2023) Glossectomy. StatPearls Publishing, Book title"},{"key":"5516_CR15","unstructured":"Copyright \u00a9 2023, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Oluwafunmilola Okuyemi declares no relevant financial relationships with ineligible companies."},{"key":"5516_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12070-022-03380-y","volume":"75","author":"FAL Deva","year":"2023","unstructured":"Deva FAL, Kalsotra G, Kalsotra P, Saraf A (2023) Tissue transfer after tongue resection: micro-vascular reconstruction using radial artery free flap versus reconstruction by split thickness skin graft in T2 lesions of tongue carcinoma. Indian J Otolaryngol Head Neck Surg\u202f: Off Publ Assoc Otolaryngol India 75:529\u2013539. https:\/\/doi.org\/10.1007\/s12070-022-03380-y","journal-title":"Indian J Otolaryngol Head Neck Surg : Off Publ Assoc Otolaryngol India"},{"key":"5516_CR17","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1016\/j.jfma.2022.07.007","volume":"121","author":"CC Huang","year":"2022","unstructured":"Huang CC, Yang TL, Tseng WH, Lee TC, Ko JY (2022) An alternative surgical technique for advanced tongue\/tongue base cancer without free flap reconstruction. J Formos Med Assoc Taiwan yi zhi 121:2626\u20132632. https:\/\/doi.org\/10.1016\/j.jfma.2022.07.007","journal-title":"J Formos Med Assoc Taiwan yi zhi"},{"key":"5516_CR18","doi-asserted-by":"publisher","unstructured":"Brudasca I, Philouze P, Morini\u00e8re S, Lallemant B, Vergez S, Malard O, Roux PE, Rossello N, Payen C and C\u00e9ruse P (2023) Transoral Laser microsurgery versus robot-assisted surgery for squamous cell carcinoma of the tongue base (oncological and functional results)-a retrospective GETTEC multicenter study. Journal of clinical medicine 12. https:\/\/doi.org\/10.3390\/jcm12134210","DOI":"10.3390\/jcm12134210"},{"key":"5516_CR19","doi-asserted-by":"publisher","unstructured":"Jozkowiak M, Dyszkiewicz-Konwinska M, Ramlau P, Kranc W, Spaczynska J, Wierzchowski M, Kaczmarek M, Jodynis-Liebert J and Piotrowska-Kempisty H (2021) Individual and combined treatments with methylated resveratrol analogue DMU-214 and gefitinib inhibit tongue cancer cells growth via apoptosis induction and EGFR inhibition. International journal of molecular sciences 22. https:\/\/doi.org\/10.3390\/ijms22126180","DOI":"10.3390\/ijms22126180"},{"key":"5516_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.oraloncology.2017.08.020","volume":"73","author":"KY Zhan","year":"2017","unstructured":"Zhan KY, Eskander A, Kang SY, Old MO, Ozer E, Agrawal AA, Carrau RL, Rocco JW, Teknos TN (2017) Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base. Oral Oncol 73:152\u2013159. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.08.020","journal-title":"Oral Oncol"},{"issue":"7","key":"5516_CR21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3390\/v13071234","volume":"13","author":"PL Stern","year":"2021","unstructured":"Stern PL, Dalianis T (2021) Oropharyngeal squamous cell carcinoma treatment in the era of immune checkpoint inhibitors. Viruses 13(7):1234. https:\/\/doi.org\/10.3390\/v13071234","journal-title":"Viruses"},{"key":"5516_CR22","doi-asserted-by":"publisher","first-page":"1504398","DOI":"10.1080\/16549716.2018.1504398","volume":"11","author":"AW Maula","year":"2018","unstructured":"Maula AW, Fuad A, Utarini A (2018) Ten-years trend of dengue research in Indonesia and South-east Asian countries: a bibliometric analysis. Glob Health Action 11:1504398. https:\/\/doi.org\/10.1080\/16549716.2018.1504398","journal-title":"Glob Health Action"},{"key":"5516_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5534\/wjmh.180114","volume":"39","author":"S Baskaran","year":"2021","unstructured":"Baskaran S, Agarwal A, Leisegang K, Pushparaj PN, Panner Selvam MK, Henkel R (2021) An in-depth bibliometric analysis and current perspective on male infertility research. World J Men\u2019s Health 39:302\u2013314. https:\/\/doi.org\/10.5534\/wjmh.180114","journal-title":"World J Men's Health"},{"key":"5516_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jocd.12198","volume":"15","author":"M Rondanelli","year":"2016","unstructured":"Rondanelli M, Perna S, Peroni G, Guido D (2016) A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia. J Cosmet Dermatol 15:120\u2013130. https:\/\/doi.org\/10.1111\/jocd.12198","journal-title":"J Cosmet Dermatol"},{"key":"5516_CR25","doi-asserted-by":"publisher","first-page":"843735","DOI":"10.3389\/fonc.2022.843735","volume":"12","author":"Z Shen","year":"2022","unstructured":"Shen Z, Wu H, Chen Z, Hu J, Pan J, Kong J, Lin T (2022) The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis. Front Oncol 12:843735. https:\/\/doi.org\/10.3389\/fonc.2022.843735","journal-title":"Front Oncol"},{"key":"5516_CR26","doi-asserted-by":"publisher","first-page":"627891","DOI":"10.3389\/fonc.2020.627891","volume":"10","author":"C Ma","year":"2020","unstructured":"Ma C, Su H, Li H (2020) Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study. Front Oncol 10:627891. https:\/\/doi.org\/10.3389\/fonc.2020.627891","journal-title":"Front Oncol"},{"key":"5516_CR27","doi-asserted-by":"publisher","first-page":"734514","DOI":"10.3389\/fcvm.2021.734514","volume":"8","author":"D Ma","year":"2021","unstructured":"Ma D, Guan B, Song L, Liu Q, Fan Y, Zhao L, Wang T, Zhang Z, Gao Z, Li S, Xu H (2021) A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med 8:734514. https:\/\/doi.org\/10.3389\/fcvm.2021.734514","journal-title":"Front Cardiovasc Med"},{"key":"5516_CR28","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.2147\/jpr.S340961","volume":"14","author":"L Huang","year":"2021","unstructured":"Huang L, Xu G, He J, Tian H, Zhou Z, Huang F, Liu Y, Sun M, Liang F (2021) Bibliometric analysis of functional magnetic resonance imaging studies on acupuncture analgesia over the past 20 years. J Pain Res 14:3773\u20133789. https:\/\/doi.org\/10.2147\/jpr.S340961","journal-title":"J Pain Res"},{"key":"5516_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1056\/NEJMoa1506007","volume":"373","author":"AK D'Cruz","year":"2015","unstructured":"D\u2019Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1506007","journal-title":"N Engl J Med"},{"key":"5516_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/jpr.S132808","volume":"10","author":"YD Liang","year":"2017","unstructured":"Liang YD, Li Y, Zhao J, Wang XY, Zhu HZ, Chen XH (2017) Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res 10:951\u2013964. https:\/\/doi.org\/10.2147\/jpr.S132808","journal-title":"J Pain Res"},{"key":"5516_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11604-020-01047-8","volume":"39","author":"A Baba","year":"2021","unstructured":"Baba A, Hashimoto K, Kayama R, Yamauchi H, Ikeda K, Hiroya O (2021) to: Radiological approach for the newly incorporated T staging factor, depth of invasion(DOI), of the oral tongue cancer in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual: assessment of the necessity for elective neck dissection. Jpn J Radiol 39:100","journal-title":"Jpn J Radiol"},{"key":"5516_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.oraloncology.2019.01.021","volume":"91","author":"MH Mao","year":"2019","unstructured":"Mao MH, Wang S, Feng ZE, Li JZ, Li H, Qin LZ, Han ZX (2019) Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. Prospect Cohort Stud Oral Oncol 91:79\u201384. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.01.021","journal-title":"Prospect Cohort Stud Oral Oncol"},{"key":"5516_CR33","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.acra.2018.08.021","volume":"26","author":"R Murakami","year":"2019","unstructured":"Murakami R, Shiraishi S, Yoshida R, Sakata J, Yamana K, Hirosue A, Uchiyama Y, Nakayama H, Yamashita Y (2019) Reliability of MRI-derived depth of invasion of oral tongue cancer. Acad Radiol 26:e180\u2013e186. https:\/\/doi.org\/10.1016\/j.acra.2018.08.021","journal-title":"Acad Radiol"},{"key":"5516_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.oraloncology.2011.11.007","volume":"48","author":"LJ Melchers","year":"2012","unstructured":"Melchers LJ, Schuuring E, van Dijk BA, de Bock GH, Witjes MJ, van der Laan BF, van der Wal JE, Roodenburg JL (2012) Tumour infiltration depth \u22654 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol 48:337\u2013342. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.11.007","journal-title":"Oral Oncol"},{"key":"5516_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12105-017-0814-1","volume":"11","author":"Y Hori","year":"2017","unstructured":"Hori Y, Kubota A, Yokose T, Furukawa M, Matsushita T, Takita M, Mitsunaga S, Mizoguchi N, Nonaka T, Nakayama Y, Oridate N (2017) Predictive significance of tumor depth and budding for late lymph node metastases in patients with clinical N0 early oral tongue carcinoma. Head Neck Pathol 11:477\u2013486. https:\/\/doi.org\/10.1007\/s12105-017-0814-1","journal-title":"Head Neck Pathol"},{"key":"5516_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/jop.12121","volume":"43","author":"H Marangon Junior","year":"2014","unstructured":"Marangon Junior H, Rocha VN, Leite CF, de Aguiar MC, Souza PE, Horta MC (2014) Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma. J Pathol Med\u202f: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 43:199\u2013204. https:\/\/doi.org\/10.1111\/jop.12121","journal-title":"J Pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"5516_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/jop.12242","volume":"44","author":"N Xie","year":"2015","unstructured":"Xie N, Wang C, Liu X, Li R, Hou J, Chen X, Huang H (2015) Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral pathol Med\u202f: Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 44:266\u2013272. https:\/\/doi.org\/10.1111\/jop.12242","journal-title":"J Oral pathol Med : Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol"},{"key":"5516_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hed.23380","volume":"36","author":"A Almangush","year":"2014","unstructured":"Almangush A, Bello IO, Keski-S\u00e4ntti H, M\u00e4kinen LK, Kauppila JH, Pukkila M, Hagstr\u00f6m J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Gr\u00e9nman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36:811\u2013818. https:\/\/doi.org\/10.1002\/hed.23380","journal-title":"Head Neck"},{"key":"5516_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/his.12471","volume":"65","author":"A Almangush","year":"2014","unstructured":"Almangush A, Salo T, Hagstr\u00f6m J, Leivo I (2014) Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology 65:587\u2013594. https:\/\/doi.org\/10.1111\/his.12471","journal-title":"Histopathology"},{"key":"5516_CR40","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.3892\/ol.2020.11358","volume":"19","author":"M Hamada","year":"2020","unstructured":"Hamada M, Ebihara Y, Nagata K, Yano M, Kogashiwa Y, Nakahira M, Sugasawa M, Nagatsuka H, Yasuda M (2020) Podoplanin is an efficient predictor of neck lymph node metastasis in tongue squamous cell carcinoma with low tumor budding grade. Oncol Lett 19:2602\u20132608. https:\/\/doi.org\/10.3892\/ol.2020.11358","journal-title":"Oncol Lett"},{"key":"5516_CR41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jso.25334","volume":"119","author":"N Yamakawa","year":"2019","unstructured":"Yamakawa N, Kirita T, Umeda M, Yanamoto S, Ota Y, Otsuru M, Okura M, Kurita H, Yamada SI, Hasegawa T, Aikawa T, Komori T, Ueda M (2019) Tumor budding and adjacent tissue at the invasive front correlate with delayed neck metastasis in clinical early-stage tongue squamous cell carcinoma. J Surg Oncol 119:370\u2013378. https:\/\/doi.org\/10.1002\/jso.25334","journal-title":"J Surg Oncol"},{"key":"5516_CR42","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/hed.25170","volume":"40","author":"D Nair","year":"2018","unstructured":"Nair D, Mair M, Singhvi H, Mishra A, Nair S, Agrawal J, Chaturvedi P (2018) Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck 40:1780\u20131787. https:\/\/doi.org\/10.1002\/hed.25170","journal-title":"Head Neck"},{"key":"5516_CR43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamaoto.2016.3795","volume":"143","author":"RJ Cassidy","year":"2017","unstructured":"Cassidy RJ, Switchenko JM, Jegadeesh N, Sayan M, Ferris MJ, Eaton BR, Higgins KA, Wadsworth JT, Magliocca KR, Saba NF, Beitler JJ (2017) Association of lymphovascular space invasion with locoregional failure and survival in patients with node-negative oral tongue cancers. JAMA Otolaryngol Head Neck Surg 143:382\u2013388","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"5516_CR44","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00405-012-2317-8","volume":"270","author":"M Alicandri-Ciufelli","year":"2013","unstructured":"Alicandri-Ciufelli M, Bonali M, Piccinini A, Marra L, Ghidini A, Cunsolo EM, Maiorana A, Presutti L, Conte PF (2013) Surgical margins in head and neck squamous cell carcinoma: what is \u201cclose\u201d? Eur Arch Oto-Rhino 270:2603\u20139. https:\/\/doi.org\/10.1007\/s00405-012-2317-8","journal-title":"Eur Arch Oto-Rhino"},{"key":"5516_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jamaoto.2016.4238","volume":"143","author":"DK Zanoni","year":"2017","unstructured":"Zanoni DK, Migliacci JC, Xu B, Katabi N, Montero PH, Ganly I, Shah JP, Wong RJ, Ghossein RA, Patel SG (2017) A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue. JAMA Otolaryngol Neck Surg 143:555\u2013560. https:\/\/doi.org\/10.1001\/jamaoto.2016.4238","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"5516_CR46","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/j.oraloncology.2020.104938","volume":"111","author":"A Singh","year":"2020","unstructured":"Singh A, Mishra A, Singhvi H, Sharin F, Bal M, Laskar SG, Prabhash K, Chaturvedi P (2020) Optimum surgical margins in squamous cell carcinoma of the oral tongue: Is the current definition adequate? Oral Oncol 111:104938. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104938","journal-title":"Oral Oncol"},{"key":"5516_CR47","doi-asserted-by":"publisher","first-page":"106023","DOI":"10.1016\/j.oraloncology.2022.106023","volume":"133","author":"KJ de Koning","year":"2022","unstructured":"de Koning KJ, van Es RJJ, Klijn RJ, Breimer GE, Willem Dankbaar J, Braunius WW, van Cann EM, Dieleman FJ, Rijken JA, Tijink BM, de Bree R, Noorlag R (2022) Application and accuracy of ultrasound-guided resections of tongue cancer. Oral Oncol 133:106023. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.106023","journal-title":"Oral Oncol"},{"key":"5516_CR48","doi-asserted-by":"publisher","first-page":"105249","DOI":"10.1016\/j.oraloncology.2021.105249","volume":"116","author":"KJ de Koning","year":"2021","unstructured":"de Koning KJ, Koppes SA, de Bree R, Dankbaar JW, Willems SM, van Es RJJ, Noorlag R (2021) Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - comparison with conventional treatment. Oral Oncol 116:105249. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105249","journal-title":"Oral Oncol"},{"key":"5516_CR49","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0194599817742856","volume":"158","author":"O Tarabichi","year":"2018","unstructured":"Tarabichi O, Kanumuri V, Juliano AF, Faquin WC, Cunnane ME, Varvares MA (2018) Intraoperative ultrasound in oral tongue cancer resection: feasibility study and early outcomes. Otolaryngol-Head Neck Surg 158:645\u2013648. https:\/\/doi.org\/10.1177\/0194599817742856","journal-title":"Otolaryngol-Head Neck Surg"},{"key":"5516_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709\u2013720. https:\/\/doi.org\/10.1093\/jnci\/92.9.709","journal-title":"J Natl Cancer Inst"},{"key":"5516_CR51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G","volume":"89","author":"H Mellin","year":"2000","unstructured":"Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89:300\u2013304","journal-title":"Int J Cancer"},{"key":"5516_CR52","volume-title":"Monograph on the evaluation of carcinogenic risks to humans","author":"Lyon","year":"2007","unstructured":"Lyon (2007) Monograph on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, France"},{"key":"5516_CR53","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/ijc.25625","volume":"128","author":"P Attner","year":"2011","unstructured":"Attner P, Du J, N\u00e4sman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2011) Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 128:2892\u20132897. https:\/\/doi.org\/10.1002\/ijc.25625","journal-title":"Int J Cancer"},{"key":"5516_CR54","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12885-017-3642-5","volume":"17","author":"S Park","year":"2017","unstructured":"Park S, Eom K, Kim J, Bang H, Wang HY, Ahn S, Kim G, Jang H, Kim S, Lee D, Park KH, Lee H (2017) MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 17:658. https:\/\/doi.org\/10.1186\/s12885-017-3642-5","journal-title":"BMC Cancer"},{"key":"5516_CR55","doi-asserted-by":"publisher","unstructured":"Go\u0142\u0105bek K, Hudy D, \u015awi\u0119tek A, Ga\u017adzicka J, D\u0105browska N, Mi\u015bkiewicz-Orczyk K, Zi\u0119ba N, Misio\u0142ek M and Strzelczyk JK (2023) miR-125b-5p, miR-155\u20133p, and miR-214\u20135p and target E2F2 gene in oral squamous cell carcinoma. International journal of molecular sciences 24. https:\/\/doi.org\/10.3390\/ijms24076320","DOI":"10.3390\/ijms24076320"},{"key":"5516_CR56","doi-asserted-by":"publisher","first-page":"35339","DOI":"10.18632\/oncotarget.15240","volume":"8","author":"C Bersani","year":"2017","unstructured":"Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, \u00c4hrlund-Richter A, Tertipis N, Munck-Wikland E, N\u00e4sman A, Ramqvist T, Dalianis T (2017) Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget 8:35339\u201335350. https:\/\/doi.org\/10.18632\/oncotarget.15240","journal-title":"Oncotarget"},{"key":"5516_CR57","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","volume":"24","author":"CU Blank","year":"2018","unstructured":"Blank CU, Rozeman EA, Fanchi LF, Sikorska K, van de Wiel B, Kvistborg P, Krijgsman O, van den Braber M, Philips D, Broeks A, van Thienen JV, Mallo HA, Adriaansz S, Ter Meulen S, Pronk LM, Grijpink-Ongering LG, Bruining A, Gittelman RM, Warren S, van Tinteren H, Peeper DS, Haanen J, van Akkooi ACJ, Schumacher TN (2018) Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat Med 24:1655\u20131661. https:\/\/doi.org\/10.1038\/s41591-018-0198-0","journal-title":"Nat Med"},{"key":"5516_CR58","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/s1470-2045(19)30151-2","volume":"20","author":"EA Rozeman","year":"2019","unstructured":"Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch\u2019ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen J, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU (2019) Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. Lancet Oncol 20:948\u2013960. https:\/\/doi.org\/10.1016\/s1470-2045(19)30151-2","journal-title":"Lancet Oncol"},{"key":"5516_CR59","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/jco.18.01148","volume":"36","author":"A Necchi","year":"2018","unstructured":"Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucian\u00f2 R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Far\u00e8 E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS, Chung JH, Salvioni R, Mariani L, Montorsi F (2018) Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol\u202f: Off J Am Soc Clin Oncol 36:3353\u20133360. https:\/\/doi.org\/10.1200\/jco.18.01148","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"5516_CR60","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O\u2019Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25:477\u2013486. https:\/\/doi.org\/10.1038\/s41591-018-0337-7","journal-title":"Nat Med"},{"key":"5516_CR61","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41591-018-0339-5","volume":"25","author":"KA Schalper","year":"2019","unstructured":"Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, L\u00f3pez-Janeiro A, Porciuncula A, Idoate MA, Inog\u00e9s S, de Andrea C, L\u00f3pez-Diaz de Cerio A, Tejada S, Berraondo P, Villarroel-Espindola F, Choi J, G\u00farpide A, Giraldez M, Goicoechea I, Gallego Perez-Larraya J, Sanmamed MF, Perez-Gracia JL, Melero I (2019) Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat Med 25:470\u2013476. https:\/\/doi.org\/10.1038\/s41591-018-0339-5","journal-title":"Nat Med"},{"key":"5516_CR62","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/s0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R, Souli\u00e8res D, Tahara M, de Castro G, Psyrri A, Bast\u00e9 N, Neupane P, Bratland \u00c5, Fuereder T, Hughes BGM, Mes\u00eda R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, Gonz\u00e1lez Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet (London, England) 394:1915\u20131928. https:\/\/doi.org\/10.1016\/s0140-6736(19)32591-7","journal-title":"Lancet (London, England)"},{"key":"5516_CR63","first-page":"707","volume":"24","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yan J, Ren X, Sheng Y, Wang Z, Liang J, Yan Y, Jia Y, Li Z, Hou J (2022) Nimotuzumab combined with neoadjuvant or induction chemotherapy for head and neck squamous cell carcinoma: a retrospective study 24:707\u2013716","journal-title":"Nimotuzumab combined with neoadjuvant or induction chemotherapy for head and neck squamous cell carcinoma: a retrospective study"},{"key":"5516_CR64","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hed.26935","volume":"44","author":"N Amin","year":"2022","unstructured":"Amin N, Maroun CA, El Asmar M, Alkhatib HH, Guller M, Herberg ME, Zhu G, Seiwert TY, Pardoll D, Eisele DW, Fakhry C, Gourin CG, Mandal R (2022) Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review. Head Neck 44:562\u2013571. https:\/\/doi.org\/10.1002\/hed.26935","journal-title":"Head Neck"},{"key":"5516_CR65","doi-asserted-by":"publisher","first-page":"727433","DOI":"10.3389\/fonc.2021.727433","volume":"11","author":"H Shibata","year":"2021","unstructured":"Shibata H, Saito S, Uppaluri R (2021) Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy. Front Oncol 11:727433. https:\/\/doi.org\/10.3389\/fonc.2021.727433","journal-title":"Front Oncol"},{"key":"5516_CR66","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jamaoncol.2020.2955","volume":"6","author":"JD Schoenfeld","year":"2020","unstructured":"Schoenfeld JD, Hanna GJ, Jo VY, Rawal B, Chen YH, Catalano PS, Lako A, Ciantra Z, Weirather JL, Criscitiello S, Luoma A, Chau N, Lorch J, Kass JI, Annino D, Goguen L, Desai A, Ross B, Shah HJ, Jacene HA, Margalit DN, Tishler RB, Wucherpfennig KW, Rodig SJ, Uppaluri R, Haddad RI (2020) Neoadjuvant nivolumab or nivolumab plus ipilimumab in untreated oral cavity squamous cell carcinoma: a phase 2 open-label randomized clinical trial. JAMA Oncol 6:1563\u20131570. https:\/\/doi.org\/10.1001\/jamaoncol.2020.2955","journal-title":"JAMA Oncol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-024-05516-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T05:03:20Z","timestamp":1708923800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-024-05516-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5516"],"URL":"https:\/\/doi.org\/10.1007\/s00784-024-05516-6","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}